COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 672: Articles 6711-6720  | Next

Effect of Pranayama on Perceived Stress, Well Being and Quality of Life of Frontline Healthcare Professionals on Covid-19 Duty: A Quasi- Randomized Clinical Trial
Sarwal, R., Dhamija, R. K., JAIN, K., Basavaraddi, I. V.
10.1101/2022.08.25.22279201 — Posted: 2022-08-28
Are female-specific cancers long-term sequelae of COVID-19? Evidence from a large-scale genome-wide cross-trait analysis
Zhao, X., Wu, X., Xiao, J., Zhang, L., Hao, Y., Xiao, C., Zhang, B., Li, J., Jiang, X.
10.1101/2022.08.25.22279195 — Posted: 2022-08-27
Antimicrobial copper as an effective and practical deterrent to surface transmission of SARS-CoV-2
Vera-Otarola, J., Mendez, N., Martinez-Valdebenito, C., Mannheim, R., Lu, K., Rhodes, S.
10.1101/2022.08.25.505365 — Posted: 2022-08-27
Niacinamide enhances cathelicidin mediated SARS-CoV-2 membrane disruption
Bhatt, T., Khedkar, S. U., Dam, B., Lall, S., Pandey, S., Kataria, S., Dias, P. M., Waskar, M., Raut, J., Sundaramurthy, V., Vemula, P. K., Ghatlia, N., Majumdar, A., Jamora, C.
10.1101/2022.08.26.505399 — Posted: 2022-08-26
SARS-CoV-2 Omicron BA.2.75 variant may be much more infective than preexisting variants
Sugano, A., Takaoka, Y., Kataguchi, H., Kumaoka, M., Ohta, M., Kimura, S., Araki, M., Morinaga, Y., Yamamoto, Y.
10.1101/2022.08.25.505217 — Posted: 2022-08-26
Correlated substitutions reveal SARS-like coronaviruses recombine frequently with a diverse set of structured gene pools
Preska Steinberg, A., Silander, O. K., Kussell, E.
10.1101/2022.08.26.505425 — Posted: 2022-08-26
Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates
Uraki, R., Iida, S., Halfmann, P. J., Yamayoshi, S., Hirata, Y., Iwatsuki-Horimoto, K., Kiso, M., Ito, M., Furusawa, Y., Ueki, H., Sakai-Tagawa, Y., Kuroda, M., Maemura, T., Kim, T., Mine, S., Kinoshita-Iwamoto, N., Li, R., Liu, Y., Larson, D., Fukushi, S., Watanabe, S., Maeda, K., Wang, Z., Ohmagari, N., Theiler, J., Fischer, W., Korber, B., Imai, M., Suzuki, T., Kawaoka, Y.
10.1101/2022.08.26.505450 — Posted: 2022-08-26
Enhancer deregulation in TET2 Mutant Clonal Hematopoiesis is associated with increased COVID-19 related inflammation severity and mortality
Binder, M., Lasho, T. L., Ismail, W. M., Ben-Crentsil, N. A., Fernandez, J. A., Kim, M., Geyer, S. M., Mazzone, A., Finke, C. M., Mangaonkar, A. A., Lee, J.-H., Hyun Kim, K., Simon, V. A., Rohakthar, F. R., Munankarmy, A., Schwager, S. M., Harrington, J. J., Snyder, M. R., Droin, N. M., Solary, E., Robertson, K. D., Wieben, E. D., Padron, E., Chia, N., Gaspar-Maia, A., Patnaik, M. M.
10.1101/2022.08.25.505316 — Posted: 2022-08-26
Predicting the efficacy of variant-modified COVID-19 vaccine boosters
Khoury, D. S., Docken, S. S., Subbarao, K., Kent, S., Davenport, M. P., Cromer, D.
10.1101/2022.08.25.22279237 — Posted: 2022-08-26
Evaluation of Secondary Chemistry due to Disinfection of Indoor Air with Germicidal Ultraviolet Lamps
Peng, Z., Jimenez, J. L.
10.1101/2022.08.25.22279238 — Posted: 2022-08-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).